Skip to main content

News Releases & Statements

News Releases & Statements

Study in Nature Medicine Shows Superior Outcomes for Patients in LLS's Paradigm-Shifting Beat AML Clinical Trial

Rye Brook, NY (Monday, October 26, 2020) - Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine journal.

Read More
33

33 Organizations Representing Millions of Patients Urge Policymakers to Adopt “Patient-First” Policy Agenda

October 13, 2020 – A coalition of 33 organizations representing millions of people with pre-existing conditions launched an unprecedented effort today by releasing their top priorities for the next Administration. The report elevates the collective voices of patients and urges elected officials to ensure all people living in the United States, including those with pre-existing conditions, have access to adequate and affordable health coverage.

Read More
The

The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19

Rye Brook, NY (Wednesday, Sept. 9, 2020) - With studies showing between 30-60% of blood cancer patients at risk of death if infected with the COVID-19 virus compared to patients who are cancer-free, The Leukemia & Lymphoma Society (LLS) announced today it is launching the first clinical trial dedicated solely to this most vulnerable population.  

Read More

PRA Health Sciences Joins The Leukemia & Lymphoma Society on Global Trial for Children with Acute Leukemia

September 3, 2020, Rye Brook, N.Y. and Raleigh, N.C. - The Leukemia & Lymphoma Society (LLS) and PRA Health Sciences (NASDAQ: PRAH) announced today a partnership to launch a first-of-its-kind global master clinical trial to develop new treatments for children with relapsed acute leukemia.

Read More
Blood

Blood Cancer Patients Need Support Now More Than Ever

(Rye Brook, NY, Sept. 1, 2020) — Having blood cancer is tough. Having blood cancer now is even tougher. Blood Cancer Awareness Month in September provides an opportunity to remind the public about the urgent need to support research to fight this deadly disease — a disease that is diagnosed every three minutes in the U.S. and has no current means of prevention. Read More

LLS’s Team In Training Resilience Challenge Adds Meaning to Miles

An Innovative Virtual Challenge to Move, Fundraise, and Commemorate Blood Cancer Awareness Month

 

 

Read More

Media Requests

Please send all media-related inquiries and interview requests to mediarelations@lls.org.  An LLS representative will respond as soon as possible.